Abstract
Currently, the percentage of non-specific myocardial lesions of non-inflammatory genesis has significantly increased in the structure of cardiovascular diseases in children and adolescents. Cardiomyopathies are a cluster of myocardial diseases that have become more of interest by cardiologists, morphologists, geneticists, and cardiac surgeons. Cardiomyopathies in children are regarded as a severe pathology characterized by a progressive course, resistance to therapy, and result in an unfavourable prognosis. The current article presents data from international publications dedicated to cardiomyopathy diagnostics in children. This article deals with terminology issues in compliance with international disease classification, primary diagnostic criteria of non-coronary myocardium pathology, and modern methods of diagnostics and pharmacotherapy.
Highlights
IntroductionCardiomyopathy (CMP) translated from the Greek (kardia heart; mys, myos - muscle; pathos - disease) means "heart muscle disease" (Bridgen, 2004)
Cardiomyopathy (CMP) translated from the Greek means "heart muscle disease" (Bridgen, 2004)
Bridgen in 1957, and it has been used for many years to refer to myocardial diseases of unknown etiology that are characterized by cardiomegaly and electrocardiogram (ECG) changes and progress toheart failure and poor prognosis
Summary
Cardiomyopathy (CMP) translated from the Greek (kardia heart; mys, myos - muscle; pathos - disease) means "heart muscle disease" (Bridgen, 2004). According to the European Society of Cardiology (ESC), CMP is a group of heterogeneous diseases characterized by myocardial pathology with structural and/or functional disorders that are not caused by coronary heart disease, hypertension, valvular defects, or congenital diseases (Elliott et al, 2008). According to ESC, CMP is a group of heterogeneous diseases characterized by myocardial pathology with structural and/or functional disorders that are not caused by coronary heart disease, hypertension, valvular defects, and congenital diseases (Elliott et al, 2008). The basis of this classification is the change in the left ventricle structure and function, taking into account family history. This classification is focused mainly on its clinical use (Fig. 1)
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
